NCT02272569View on ClinicalTrials.gov

STARflo European Safety and Efficacy Study

NACompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

July 31, 2018

Study Completion Date

July 31, 2019

Conditions
Open Angle Glaucoma
Interventions
DEVICE

STARflo Glaucoma Implant

Implantation of the STARflo Glaucoma Implant following surgical technique described in European labelling. Procedure does not require the use of anti-fibrotic medications.

Trial Locations (8)

2650

UZA, Edegem

3010

Universitatsklinik fur Augenheilkunde Inselspital, Bern

69120

University Clinic Heidelberg, Heidelberg

69417

Hopital de la Croix-Rousse, Lyon

80336

Ludwig-Maximilians-University Munich, Munich

Unknown

CHU Sart Tilman, Liège

MHAT Central Onco Hospital, Plovdiv

CHNO des Quinze Vingts, Paris

Sponsors

Lead Sponsor

iSTAR Medical
All Listed Sponsors
lead

iSTAR Medical

INDUSTRY

NCT02272569 - STARflo European Safety and Efficacy Study | Biotech Hunter | Biotech Hunter